Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug CuII(atsm)

L Cheng, CYJ Quek, LW Hung, RA Sharples… - Scientific reports, 2016 - nature.com
The administration of MPTP selectively targets the dopaminergic system resulting in
Parkinsonism-like symptoms and is commonly used as a mice model of Parkinson's disease …

The protective, rescue and therapeutic potential of multi-target iron-chelators for retinitis pigmentosa

B Lin, MBH Youdim - Free Radical Biology and Medicine, 2021 - Elsevier
Retinitis pigmentosa (RP) is a group of inherited diseases in which mutations result in the
initial loss of night vision, followed by complete blindness. There is currently no effective …

Probing the multitargeting potential of n-hexane fraction of Gongronema latifolium leaves in neurodegeneration via in vitro, GC–MS and in silico studies

GA Gyebi, JC Ejoh, OM Ogunyemi, AM Ibrahim… - Future Journal of …, 2023 - Springer
Abstract Background Neurodegenerative disorders (NDDs) are associated with increased
activities of brain acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and …

Modulatory Effects of Alkaloid Extract from Gongronema latifolium (Utazi) and Lasianthera africana (Editan) on Activities of Enzymes Relevant to Neurodegeneration

EE Nwanna, AA Adebayo, G Oboh… - Journal of dietary …, 2019 - Taylor & Francis
Most alkaloids are produced by plants as a defense mechanism against herbivores. Since
alkaloids are known to possess pharmacological effects, this study sought to investigate the …

Identification of potential inhibitors of cholinergic and β-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: an integrated …

GA Gyebi, OM Ogunyemi, IM Ibrahim, OB Ogunro… - Molecular Diversity, 2023 - Springer
Neurodegenerative disorders (NDDs) are associated with increased activities of the brain
acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and β-secretase enzyme …

[HTML][HTML] The Molecular Mechanism of ferroptosis and Its Relationship with Parkinson's Disease

Y Su, Y Jiao, Q Wang, X Chen - Brain Research Bulletin, 2024 - Elsevier
Neurodegenerative diseases such as Parkinson's disease (PD) have complex pathogenetic
mechanisms. Genetic, age, and environmental factors are all related to PD. Due to the …

Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1G93A Transgenic ALS Mice

S Golko-Perez, T Amit, MBH Youdim… - Journal of Molecular …, 2016 - Springer
Accumulation of evidence has demonstrated high levels of iron in the central nervous
system of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients and in ALS …

Piperazine derivatives as iron chelators: a potential application in neurobiology

S Abdelsayed, NT Ha Duong, C Bureau, PP Michel… - Biometals, 2015 - Springer
Polysubstituted piperazine derivatives, designed as new iron chelators, were synthesized
and fully characterized by nuclear magnetic resonance and mass spectroscopy. Their …

Diagnostics and treatments of iron-related CNS diseases

H Xiong, Q Tuo, Y Guo, P Lei - Brain Iron Metabolism and CNS Diseases, 2019 - Springer
Iron has been proposed to be responsible for neuronal loss in several diseases of the
central nervous system, including Alzheimer's disease (AD), Parkinson's disease (PD) …

Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases

I Cacciatore, L Marinelli, A Di Stefano, V Di Marco… - Neuropeptides, 2018 - Elsevier
Neurodegenerative diseases share a common pathogenetic mechanism involving
aggregation and deposition of misfolded proteins, oxidative stress, metal dyshomeostasis …